Elbasvir/Grazoprevir Experience - A New Glance at HCV Treatment: Case Report

dc.contributor.authorCelen, Mustafa Kemal
dc.contributor.authorAkdemir, Irem
dc.contributor.authorTekin, Recep
dc.contributor.authorBayan, Kadim
dc.contributor.authorAyaz, Celal
dc.date.accessioned2024-04-24T17:24:32Z
dc.date.available2024-04-24T17:24:32Z
dc.date.issued2017
dc.departmentDicle Üniversitesien_US
dc.description.abstractHepatitis C is a viral disease having a worldwide importance and posing a risk for liver complications. With the new treatment options, it is easy to manage with higher rates of success. Among them, one of the most recent one is elbasvir/grazoprevir option. This study presents the results of two treatment-naive patients treated with elbasvir/grazoprevir. The first case was a male non-cirrhotic patient and the second one was a female who suffered from compensated hepatic cirrhosis. Both patients received elbasvir/grazoprevir 50/100 mg in a single tablet for 12 weeks. Persistent viral response was achieved in both patients and no side effect was observed during the treatment. Elbasvir/grazoprevir combination, one of the recent treatments, was considered effective and tolerable.en_US
dc.identifier.doi10.4274/vhd.10337
dc.identifier.endpage36en_US
dc.identifier.issn1307-9441
dc.identifier.issn2147-2939
dc.identifier.issue1en_US
dc.identifier.startpage34en_US
dc.identifier.urihttps://doi.org/10.4274/vhd.10337
dc.identifier.urihttps://hdl.handle.net/11468/19722
dc.identifier.volume23en_US
dc.identifier.wosWOS:000404629300009
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherGalenos Yayinciliken_US
dc.relation.ispartofViral Hepatit Dergisi-Viral Hepatitis Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectHepatitis C Virusen_US
dc.subjectOral Antiviral Treatmenten_US
dc.subjectElbasvir/Grazopreviren_US
dc.titleElbasvir/Grazoprevir Experience - A New Glance at HCV Treatment: Case Reporten_US
dc.titleElbasvir/Grazoprevir Experience - A New Glance at HCV Treatment: Case Report
dc.typeArticleen_US

Dosyalar